An “alternative history” has revealed the potential impacts a smaller National Institutes of Health would have had on past ...

Sequel Med Tech has a plan to explore a new type of ultra-concentrated and fast-acting insulin, to see how it may work with ...

In August, the Foundation for the National Institutes of Health, a congressionally mandated nonprofit that supports the ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a sin | Eli Lilly has pulled the plug on a phase ...

Merck & Co. is choosing to license one of Evaxion’s AI platform-based vaccine candidates, offering the Danish biotech up to ...

The FDA’s rejection of Telix Pharmaceuticals’ imaging agent has triggered layoffs at Heidelberg Pharma. | The FDA’s rejection ...

Lantheus has inked a deal giving GE HealthCare the rights to carry its prostate cancer PET imaging agent in Japan, with the ...

Heartflow has secured a new FDA clearance for its artificial intelligence program to analyze the buildup of dangerous plaques ...

Sanofi is bestowing $625 million on its investment arm Sanofi Ventures, seeking to take advantage of a biotech landscape that ...

Sparrow Pharmaceuticals is looking to send its potential diabetes treatment soaring through clinical trials with the help of ...

UniQure has set its sights on submitting its Huntington’s disease gene therapy for approval next year after the asset was ...

Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate ...